FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...